Robert John Nesbitt CMP, DES

Global Conference Producer Certified Meeting Professional (CMP), Digital Event Strategist (DES) #WSC2025

[Robert John Nesbitt CMP, DES @bobnesbitt]

ARISE IV: The Neurovascular Industry Is Showing Up — Are You? https://t.co/59LEaldCLT

[Robert John Nesbitt CMP, DES @bobnesbitt]

https://t.co/vSbrfzelKk

[Robert John Nesbitt CMP, DES @bobnesbitt]

ARISE IV: The Signal Is Clear — The Next Wave of Neurovascular Innovation Is Showing Up Early https://t.co/12wXPpIMq1

[Robert John Nesbitt CMP, DES @bobnesbitt]

ARISE IV Achieves Ethical MedTech Compliance https://t.co/3sSdyunitN

[Robert John Nesbitt CMP, DES @bobnesbitt]

✨ Exciting news! I’ll attend the World Stroke Congress 2026 in Seoul, Korea, on October 21-23, 2026!
💡 Learn more: https://t.co/lfx0SvXvtu
#StrokePrevention #StrokeCare #StrokeResearch #Stroke #GlobalHealth #BrainHealth #Neurology https://t.co/9xi7wcv7W0

[Robert John Nesbitt CMP, DES @bobnesbitt]

Check out the latest article in my newsletter: ARISE IV: Look Who’s in the Room — Then Decide If You Can Afford Not to Be https://t.co/1Q34R21uxE via @LinkedIn

[Robert John Nesbitt CMP, DES @bobnesbitt]

Neurovascular is entering its system era. The companies helping define it won’t be the ones who waited. https://t.co/GSgTD6OVI6

[Robert John Nesbitt CMP, DES @bobnesbitt]

Check out the latest article in my newsletter: ARISE IV Sets a New Benchmark for Government Engagement https://t.co/J6TYdrlEOr via @LinkedIn

[Robert John Nesbitt CMP, DES @bobnesbitt]

Check out the latest article in my newsletter: The Fortnight That Redefined Neurovascular — And Why Industry Should Be in the Room https://t.co/whXHHsda4o via @LinkedIn

[Robert John Nesbitt CMP, DES @bobnesbitt]

Check out the latest article in my newsletter: ARISE IV 2026: Where Neurovascular Innovation Converges https://t.co/l91OljPqMJ via @LinkedIn

[Robert John Nesbitt CMP, DES @bobnesbitt]

@razib_ul47671 AI

[Robert John Nesbitt CMP, DES @bobnesbitt]

Check out the latest article in my newsletter: Big Medtech Doesn't Invent Its Best Technologies. Here's Where They Come From https://t.co/kXh4QZucjp via @LinkedIn

[Robert John Nesbitt CMP, DES @bobnesbitt]

https://t.co/Qo0KizzcPO

[Robert John Nesbitt CMP, DES @bobnesbitt]

Check out the latest article in my newsletter: The Neurovascular Meeting That Industry Actually Watches https://t.co/4Vezkjkkfm via @LinkedIn

[Robert John Nesbitt CMP, DES @bobnesbitt]

Are we defining stroke occlusions the wrong way? https://t.co/4yzGntv4wa

[Robert John Nesbitt CMP, DES @bobnesbitt]

Check out the latest article in my newsletter: Session 3 Spotlight – Combined Access, AI + Robotics Integration https://t.co/yyzIGRuiCW via @LinkedIn

[Robert John Nesbitt CMP, DES @bobnesbitt]

Check out the latest article in my newsletter: Session 1 Highlight – What Has ARISEN: Translating Innovation into Intervention https://t.co/g9GduuzNuc via @LinkedIn

[Robert John Nesbitt CMP, DES @bobnesbitt]

ARISE IV 2026: From Intelligence to Intervention – Exploring Ambulatory Neurointervention https://t.co/5DxNMP1ZDf

[J Mocco, MD, MS @JMoccoMD]

Today is #ThankAResidentDay, and I couldn't let it pass without saying something to our incredible residents at Weill Cornell Medicine's Department of Neurological Surgery.

Learn more about our residency program: https://t.co/wPksTERQLt

[Robert John Nesbitt CMP, DES @bobnesbitt]

Merken Sie sich das Datum vor für die Cardiovascular, Renal, Metabolic, Liver, and Obesity Conference (CaReMeLO 2026), die am 8. und 9. Mai 2026 in München, Deutschland, stattfinden wird!
Mehr erfahren: https://t.co/h1jff3LoZM

#CaReMeLO2026 https://t.co/b2AVC9OsHt